ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 190 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,280,000 | -55.1% | 47,035 | -60.9% | 0.48% | -68.4% |
| Q1 2020 | $5,079,000 | -1.4% | 120,216 | -0.1% | 1.53% | +44.9% |
| Q4 2019 | $5,150,000 | +47.1% | 120,386 | +23.8% | 1.06% | +13.6% |
| Q3 2019 | $3,500,000 | +288.0% | 97,239 | +188.1% | 0.93% | +303.0% |
| Q2 2019 | $902,000 | -44.0% | 33,746 | -43.8% | 0.23% | -48.9% |
| Q1 2019 | $1,611,000 | +0.8% | 60,009 | -39.3% | 0.45% | -13.9% |
| Q4 2018 | $1,598,000 | -17.1% | 98,806 | +6.4% | 0.52% | -5.6% |
| Q3 2018 | $1,928,000 | +79.3% | 92,885 | +160.2% | 0.56% | -36.2% |
| Q4 2017 | $1,075,000 | -1.3% | 35,701 | +23.5% | 0.87% | -22.2% |
| Q3 2017 | $1,089,000 | +109.8% | 28,919 | +55.4% | 1.12% | +73.1% |
| Q2 2017 | $519,000 | -14.6% | 18,615 | -2.6% | 0.65% | +53.0% |
| Q3 2016 | $608,000 | – | 19,110 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |